Hans Keirstead is the founder of AiVita Biomedical. AiVita Biomedical has raised $27M in total funding. Latest round: Series A. Based in Pasadena, California.
Hans Keirstead is a serial entrepreneur and the Founder, CEO, and Chairman of AiVita Biomedical, a biotechnology company focused on personalized vaccines for infectious diseases and cancer treatment. He has guided the company through multiple clinical trial phases, including securing Phase 3 approval for a cancer immunotherapy.
Full founder directory · Investor directory · Company funding database · Fundraising library